[OurCrowd CEO Jon Medved in The Jerusalem Post] Expect a ‘renaissance’ in medical innovation, says OurCrowd chief
Jonathan Medved, CEO of the Jerusalem-based global investment platform OurCrowd, told The Media Line that the outbreak had shifted the focus of many investors in a way that could have far-reaching implications for medical innovation. Read...
Read More